Aptevo Therapeutics, Inc. (NASDAQ:APVO) stock is trading lower Friday after the company announced a 1-for-37 reverse stock split.

The Details: The goal of the reverse stock split is to regain compliance with minimum bid price requirement of $1.00 per share required to maintain continued listing on the Nasdaq.

Shares will begin trading on a split-adjusted basis on December 4 at market open. The reverse stock split will reduce the number of shares of the company’s outstanding common stock from approximately 18.5 million shares to 0.5 million shares.

It was approved by Aptevo’s shareholders at a special meeting held on Oct. 25, 2024.

How To Buy Aptevo Shares

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Aptevo Therapeutics's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

APVO Price Action: At the time of writing Aptevo shares are trading 18.9% lower at 28 cents, according to data from Benzinga Pro.

Image: 6368031 from Pixabay.